|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0039198,
umls-concept:C0079772,
umls-concept:C0085862,
umls-concept:C0184511,
umls-concept:C0205210,
umls-concept:C0205217,
umls-concept:C1265611,
umls-concept:C1274040,
umls-concept:C1299583,
umls-concept:C1517067,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C2698872
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-9-23
|
|
pubmed:abstractText |
Extranodal natural killer/T-cell lymphoma (NKTCL) is a clinically heterogeneous disease with a poor prognosis, requiring risk-stratified management in affected patients. Recently, tumor microenvironment including regulatory T cells (Tregs) has been implicated as a prognostic marker in certain types of lymphoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1688-96
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19542249-Disease Progression,
pubmed-meshheading:19542249-Disease-Free Survival,
pubmed-meshheading:19542249-Female,
pubmed-meshheading:19542249-Follow-Up Studies,
pubmed-meshheading:19542249-Forkhead Transcription Factors,
pubmed-meshheading:19542249-Humans,
pubmed-meshheading:19542249-Immunohistochemistry,
pubmed-meshheading:19542249-Kaplan-Meier Estimate,
pubmed-meshheading:19542249-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:19542249-Lymphoma, T-Cell,
pubmed-meshheading:19542249-Male,
pubmed-meshheading:19542249-Middle Aged,
pubmed-meshheading:19542249-Multivariate Analysis,
pubmed-meshheading:19542249-Natural Killer T-Cells,
pubmed-meshheading:19542249-Neoplasm Staging,
pubmed-meshheading:19542249-Prognosis,
pubmed-meshheading:19542249-Survival Analysis,
pubmed-meshheading:19542249-T-Lymphocytes, Regulatory,
pubmed-meshheading:19542249-Time Factors
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.
|
|
pubmed:affiliation |
Department of Pathology, Seoul National University Hospital, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
